Regenxbio
Maryland, United States
501-1000 Employees
Automotive
•Healthcare
•Tech
Director, Toxicology and Translational Sciences
Rockville, --
Description
REGENXBIO is a leading biotechnology company focused on developing and delivering gene therapies for a range of genetic diseases. Founded in 2008, the company has been at the forefront of innovation in gene therapy, leveraging its proprietary NAV Technology Platform to create transformative treatments. With a commitment to advancing the field of gene therapy, REGENXBIO is dedicated to improving the lives of patients through cutting-edge genetic medicine.
Financials
Type
public
Annual Revenue
--
Market Cap
$435.7M+
Subscribe to Refer Me premium to get referred to this role at Regenxbio!